Contact Shire

Thank you for your interest in Daytrana™, the first and only patch for Attention Deficit Hyperactivity Disorder (ADHD) treatment, from Shire. We welcome your comments and questions.

U.S. Headquarters

Shire US Inc.
725 Chesterbrook Blvd.
Wayne, PA 19087-5367
Toll free: (800) 828-2088

Patients and caregivers

Call the Shire Customer Service Center toll free at (800) 828-2088; M-F 8:30 am to 5:30 pm ET.

Healthcare professionals

Clinical inquiries: For further clinical information on Shire products, U.S. healthcare professionals may call toll free at (800) 828-2088, or send an e-mail to medinfoGlobal@shire.com.

Important Safety Information

Tell your doctor about any heart conditions, including structural abnormalities, your child or a family member may have. Inform your doctor immediately if the child develops symptoms that suggest heart problems, such as chest pain or fainting.

Daytrana should not be used if the child has: significant anxiety, tension, or agitation; allergies to methylphenidate or other ingredients of Daytrana; glaucoma; discontinued in the last 14 days or is taking a monoamine oxidase inhibitor (MAOI); tics, or family history or diagnosis of Tourette’s syndrome.

Tell your doctor before using Daytrana if the child: is being treated for or has symptoms of depression (e.g. sadness, worthlessness, or hopelessness) or bipolar disorder; has family history of tics; has abnormal thoughts or visions, hears abnormal sounds, or has been diagnosed with psychosis; has had seizures or abnormal EEGs; has or has had high blood pressure; exhibits aggressive behavior or hostility. Tell your doctor immediately if the child develops any of these conditions/symptoms while using Daytrana.

In clinical studies, side effects were generally mild to moderate. The most common side effects reported with Daytrana were decreased appetite, sleeplessness, sadness/crying, twitching, weight loss, nausea, vomiting, tics, and affect lability (mood swings). Aggression, new abnormal thoughts/behaviors, mania, and growth suppression have been associated with use of drugs of this type. Tell your doctor if the child has blurred vision while using Daytrana.

Abuse of Daytrana can lead to dependence.

Daytrana should be applied daily to clean, dry skin, which is free of any cuts or irritation. Skin redness or itching is common with Daytrana. Allergic skin rash may occur.

Please see Full Prescribing Information and Medication Guide.

DAYTRANA^® is a registered trademark of Shire Pharmaceuticals Ireland Limited.
©2008 Shire US Inc., Wayne, PA 19087. DAY-00043 08/08

This site/ is strictly intended for U.S. residents and is governed solely by U.S. laws and governmental regulations. Please see our online privacy policy for more information.

While Shire US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Shire US Inc. makes no warranties or representations as to its accuracy. Shire US Inc. assumes no liability for any errors or omissions in the content of the site.